NewAmsterdam Pharma Company N.V. NAMSW

Set alert

Price alert · NAMSW

All alert types
9.50 USD +0.52 +5.74%

As of Nov 2, 2:17 PM ET

Bid
9.08 × —
Ask
10.39 × —
9.49 Day range 9.55
8.25 52-week range 30.45
YTD
-58.70%
1 year
-64.79%
Open
24.41
Prev close
8.98
Mkt cap
2.35B
Vol
15.35K
Avg vol
1.24K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
9.49
High
9.55
Forward P/E
0.00
Beta
0.14
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2026
50-d avg
12.07
200-d avg
18.97
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NAMSW has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $21.86MExpenses → Selling, General & Admin: $106.30MExpenses → Research & Development: $141.83MGross Profit → Expenses: $22.44MRevenue → Gross Profit: $22.44MRevenue → Cost of Revenue: $59.00KNet Loss → Expenses: $203.82MOther Income$21.86MGross Profit$22.44MNet Loss$203.82MCost of Revenue$59.00KExpenses$248.13MSelling, General & Admin$106.30MResearch & Development$141.83MRevenue$22.50M

No annual statement lines

NAMSW has no annual lines for this statement.